Bullish
Does BioCryst’s European Navenibart Licensing Deal and Cash Infusion Change The Bull Case For BCRX?
BioCryst Pharmaceuticals secured a European licensing deal for its investigational HAE therapy, navenibart, with an Irish affiliate of Neopharmed Gent...